Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer

DSpace Repository

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer

Author: Hortobagyi, G. N.; Stemmer, S. M.; Burris, H. A.; Yap, Y. -S.; Sonke, G. S.; Paluch-Shimon, S.; Campone, M.; Blackwell, K. L.; Andre, F.; Winer, E. P.; Janni, W.; Verma, S.; Conte, P.; Arteaga, C. L.; Cameron, D. A.; Petrakova, K.; Hart, L. L.; Villanueva, C.; Chan, A.; Jakobsen, E.; Nusch, A.; Burdaeva, O.; Grischke, E. -M.; Alba, E.; Wist, E.; Marschner, N.; Favret, A. M.; Yardley, D.; Bachelot, T.; Tseng, L. -M.; Blau, S.; Xuan, F.; Souami, F.; Miller, M.; Germa, C.; Hirawat, S.; O'Shaughnessy, J.
Tübinger Autor(en):
Grischke, Eva-Maria
Published in: New England Journal of Medicine (2016), Bd. 375, H. 18, S. 1738-1748
Verlagsangabe: Massachusetts Medical Soc
Language: English
Full text: http://dx.doi.org/10.1056/NEJMoa1609709
ISSN: 1533-4406
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)